Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Corvus Pharmaceuticals, Inc. (CRVS) Misses Q3 EPS by 49c

November 12, 2024 4:03 PM EST

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) reported Q3 EPS of ($0.60), $0.49 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Corvus Pharmaceuticals, Inc. (CRVS) click here.

... More